Feng, whose work focuses on liver cancer and immunotherapy, will lead research institute at Shenzhen Bay Laboratory after 40 years abroad
Distinguished cancer expert Feng Gensheng has returned to China this month after 40 years in North America, mostly in the United States.
SZBL is a research platform established by Guangdong province and the southern city of Shenzhen to build leading science and technology innovation centres.
This type of enzyme can affect the stability of proteins and regulate the activity of other enzymes, which helps us understand the regeneration and differentiation mechanisms of various cells.
Feng, a fellow of the American Association for the Advancement of Science (AAAS), confirmed he had returned to China.
